# Elicio Therapeutics, Inc. — Form D

Elicio Therapeutics, Inc. of Boston, MA, a company, filed a Form D exempt-offering notice with the SEC on 2015-02-20. The offering totals $15.0M, of which $4.4M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2015-02-20
- Form: D
- Accession: 0001571049-15-001301
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $4.4M
- Remaining: $10.6M
- Minimum investment: $16K
- Investors: 23
- Date of first sale: 2015-01-07
- Security types: equity
- Revenue range: $1,000,001 - $5,000,000
- SEC file number: 021-234480

## Issuer

- Name: Elicio Therapeutics, Inc.
- CIK: 0001601485
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 451 D Street, Boston, MA, 02210
- Phone: (857) 209-0050

## Officers, directors & promoters (24)

| Name | Role | Location |
| --- | --- | --- |
| Yekaterina Chudnovsky | Director | LOS ANGELES, CA |
| Karen Wilson | Director | Boston, MA |
| Christopher Haqq | Executive Officer | Boston, MA |
| Jay Venkatesan | Director | Boston, MA |
| Carol Ashe | Director | Boston, MA |
| Brian Piekos | Executive Officer | Boston, MA |
| Robert Connelly | Director | Boston, MA |
| Robert Connelly | Executive Officer | Boston, MA |
| Allen Nissenson | Director | Boston, MA |
| Robert Ruffolo | Director | Boston, MA |
| Peter DeMuth | Executive Officer | Boston, MA |
| Julian Adams | Director | Boston, MA |
| Allen R Nissenson | Director | San Francisco, CA |
| Jay R Venkatesan | Director | San Francisco, CA |
| Jay R Venkatesan | Executive Officer | San Francisco, CA |
| Karen R Wilson | Director | San Francisco, CA |
| Itzhak D Goldberg | Director | Uniondale, NY |
| Itzhak D Goldberg | Executive Officer | Uniondale, NY |
| Victor R Ganzi | Director | San Francisco, CA |
| Gil R Omenn | Director | San Francisco, CA |
| Michael R Yamin | Director | Uniondale, NY |
| Jay D Venkatesan | Director | Uniondale, NY |
| Jay D Venkatesan | Executive Officer | Uniondale, NY |
| Michael D Yamin | Director | Uniondale, NY |

## Other filings by this issuer (7)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-03-29](https://search.stillhousedata.com/formd/0001601485-24-000017) | D | $6.0M | $6.0M |
| [2024-01-05](https://search.stillhousedata.com/formd/0001140361-24-001004) | D | $7.0M | $7.0M |
| [2020-06-23](https://search.stillhousedata.com/formd/0001601485-20-000004) | D | $40.0M | $6.7M |
| [2020-01-27](https://search.stillhousedata.com/formd/0001601485-20-000002) | D | $12.0M | $1.0M |
| [2020-01-13](https://search.stillhousedata.com/formd/0001601485-20-000001) | D | $12.0M | $6.1M |
| [2018-07-17](https://search.stillhousedata.com/formd/0001601485-18-000002) | D | $35.0M | $15.4M |
| [2018-07-17](https://search.stillhousedata.com/formd/0001601485-18-000001) | D | $5.4M | $5.4M |

## More

- [CIK 1601485 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1601485&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001571049-15-001301.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.